Skip to main content

Advertisement

SpringerLink
Log in

HIV and thyroid dysfunction

  • Published:
Reviews in Endocrine and Metabolic Disorders Aims and scope Submit manuscript

Abstract

Human Immunodeficiency virus (HIV) infection and Acquired Immunodeficiency Syndrome (AIDS) are associated with dysfunction of many endocrine organs and their axis. HIV infectivity leads to altered metabolism, poor oral intake and increased prevalence of weight loss and wasting which may have a role in thyroid dysfunction. Overt thyroid dysfunction occurs at similar rates as the general population while subclinical disease such as nonthyroidal illness (sick euthyroid syndrome), subclinical hypothyroidism and isolated low T4 levels are more frequent. Moreover, HAART therapy can complicate thyroid function further through drug interactions and the immune reconstitution inflammatory syndrome (IRIS). In this review we report the common thyroid dysfunctions associated with HIV before and after HAART therapy. We discuss presentation, diagnostic work up, treatment and follow up in each condition.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Boelaert K, Franklyn JA. Thyroid hormone in health and disease. J Endocrinol. 2005;187:1–15.

    Google Scholar 

  2. Franklyn JA. The thyroid- too much and too little across the ages. The consequences of subclinical thyroid dysfunction. Clin Endocrinol. 2013;78(1):1–8.

    Google Scholar 

  3. Grunfeld C, Pang M, Doerrier W, et al. Indices of thyroid function and weight loss in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Metabolism. 1993;42(10):1270–6.

    Article  PubMed  CAS  Google Scholar 

  4. Olivieri A, Sorcini M, Battisti P, et al. Thyroid hypofunction related with the progression of human immunodeficiency virus infection. J Endocrinol Invest. 1993;16:407–13.

    PubMed  CAS  Google Scholar 

  5. Kosmiski L. Energy expenditure in HIV infection. Am J Clin Nutr. 2011;94(6):16775–825.

    Article  Google Scholar 

  6. Mittelsteadt AL, Hileman CO, Harris SR, et al. Effects of HIV and antiretroviral therapy on resting energy expenditure in adult HIV-infected women—a matched, prospective, cross-sectional study. J Acad Nutr Diet. 2013. doi:10.1016/j.jand.2013.02.005.

    PubMed  Google Scholar 

  7. Mangili A, Murman DH, Zampini AM, Wanke CA, Mayer KH. Nutrition and HIV infection: review of weight loss and wasting in the era of highly active antiretroviral therapy from the nutrition for healthy living cohort. Clin Infect Dis. 2006;42(6):836–42.

    Article  PubMed  CAS  Google Scholar 

  8. Hirschfeld S, Laue L, Cutler Jr GB, Pizzo PA. Thyroid abnormalities in children infected with human immunodeficiency virus. J Pediatr. 1996;128(1):70–4.

    Article  PubMed  CAS  Google Scholar 

  9. Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002;87(2):489.

    Article  PubMed  CAS  Google Scholar 

  10. Golden SH, Robinson KA, Saldanha I, et al. Prevalence and incidence of endocrine and metabolic disorders in the United Staes: a comprehensive review. J Clin Endocrinol Metab. 2009;94(6):1853–78.

    Article  PubMed  CAS  Google Scholar 

  11. Beltran S, Lescure F-X, Esper IE, et al. Subclinical hypothyroidism in HIV infected patients is not an autoimmune disease. Horm Res. 2006;66:21–6.

    Article  PubMed  CAS  Google Scholar 

  12. Madge S, Smith C, Lampe F, et al. No association between HIV disease and its treatment and thyroid function. HIV Med. 2006;7(supp 1):23. abstract P49.

    Google Scholar 

  13. Noureldeen A, Qusti SY, Khoja GM. Thyroid function in newly diagnosed HIV-infected patients. Toxicol Ind Health. 2012. doi:10.1177/0748233712466133.

    PubMed  Google Scholar 

  14. Fundaro C, Olivieri A, Rendeli C, et al. Occurrence of anti-thyroid autoantibodies in children vertically infected with HIV-1. J Pediatr Endocrinol Metab. 1998;11(6):745–50.

    Article  PubMed  CAS  Google Scholar 

  15. Chiarelli F, Galli L, Verrotti A, et al. Thyroid function in children with perinatal human immunodeficiency virus type 1 infection. Thyroid. 2000;10(6):499–505.

    PubMed  CAS  Google Scholar 

  16. Rana S, Nunlee-Bland G, Valyasevi R, Iqbal M. Thyroid dysfunction in HIV-infected children: is L-thyroxine therapy beneficial? Pediatr AIDS HIV Infect. 1996;7(6):424–8.

    PubMed  CAS  Google Scholar 

  17. Marino R, Hegde A, Barnes KM, et al. Catch up growth after hypothyroidism is caused by delayed growth plate senescence. Endocrinology. 2008;149(4):1820–8.

    Article  PubMed  CAS  Google Scholar 

  18. Touzot M, Le Beller C, Touzot F, et al. Dramatic interaction between levothyroxine and lopinavir/ritonavir in an HIV infected patient. AIDS. 2006;20:1210–2.

    Article  PubMed  Google Scholar 

  19. Lanzafame M, Trevenzoli M, Faggian F, et al. Interaction between levothyroxine and indinavir in a patient with HIV infection. Infection. 2002;30(1):54–5.

    Article  PubMed  CAS  Google Scholar 

  20. Garber JR, Cobin RH, Gharib H, et al. Clinical practice guidelines for hypothyroidism in adults: co-sponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract. 2012;11:1–207.

    Google Scholar 

  21. Beltran S, Lescure F-X, Desailloud R, et al. Increased prevalence of hypothyroidism among human immunodeficiency virus- infected patients: a need for screening. Clin Infect Dis. 2003;37:579–83.

    Article  PubMed  Google Scholar 

  22. Merenich J, McDermott T, Asp A, et al. Evidence of endocrine involvement early in the course of human immunodeficiency virus infection. J Clin Endocrinol Metab. 1990;70:566–71.

    Article  PubMed  CAS  Google Scholar 

  23. Quirino T, Bongiovanni M, Ricci E, et al. Hypothyroidism in HIV-infected patients who have or have not received HAART. Clin Infect Dis. 2004;38(4):596–7.

    Article  PubMed  CAS  Google Scholar 

  24. Madeddu G, Spanu A, Chessa F, et al. Thyroid function in human immunodeficiency virus patients treathed with highly active antiretroviral therapy (HAART): a longitudinal study. Clin Endocrinol. 2006;64:375–83.

    CAS  Google Scholar 

  25. Calza L, Manfredi R, Chiodo F. Subclinical hypothyroidism in HIV-infected patients receiving highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2002;31:361–2.

    Article  PubMed  Google Scholar 

  26. Bongiovanni M, Adorni F, Casana M, et al. Subclinical hypothyroidism in HIV-infected patients. J Antimicrob Chemother. 2006;58(5):1086–9.

    Article  PubMed  CAS  Google Scholar 

  27. Grappin M, Piroth L, Verges B, et al. Increased prevalence of subclinical hypothyroidism in HIV patients treated with highly active antiretroviral therapy. AIDS. 2000;14:1070–2.

    Article  PubMed  CAS  Google Scholar 

  28. Hoffman CJ, Brown TT. Thyroid function abnormalities in HIV-infected patients. Clin Infect Dis. 2007;45:488–94.

    Article  Google Scholar 

  29. Sellmeyer DE, Grrunfeld C. Endocrine and metabolic disturbances in human immunodeficiency virus infection and the acquired immune deficiency syndrome. Endocr Rev. 1996;17:518–27.

    PubMed  CAS  Google Scholar 

  30. Dobs AS, Dempsy MA, Ladenson PW, Polk BF. Endocrine disorders in men infected with the human immunodeficiency virus. Am J Med. 1988;84:611–6.

    Article  PubMed  CAS  Google Scholar 

  31. Collazos J, Ibarra S, Mayo J. Thyroid hormones in HIV infected patients in the highly active antiretroviral therapy era: evidence of an interrelationship between the thyroid axis and the immune system. AIDS. 2004;17:763–5.

    Article  Google Scholar 

  32. Vigano A, Riboni S, Bianchi R, et al. Thyroid dysfunction in antiretroviral treated children. Pediatr Infect Dis J. 2004;23(3):235–9.

    Article  PubMed  Google Scholar 

  33. Raffi F, Brisseau JM, Planchon et al. Endocrine function in 98 HIV- infected patients: a prospective study. AIDS. 1991;5:729–733

  34. Zavaschi AP, Maia AL, Goldani LA. Pneumocystis jiroveci thyroiditis: report of 15 cases in the literature. Mycoses. 2007;50(6):443–6.

    Article  Google Scholar 

  35. Jinno S, Chang S, Jocobs MR. Coccidioides thyroiditis in an HIV-infected patient. J Clin Microbiol. 2012;50(7):2535–7.

    Article  PubMed  Google Scholar 

  36. Kiertiburanakul S, Sungkanuparph S, Malathum K, Pracharktam R. Concomitant tuberculous and cryptococcal thyroid abscess in a human immunodeficiency virus infected patient. Scand J Infect Dis. 2003;35(1):68–70.

    Article  PubMed  Google Scholar 

  37. Trzepacz PT, McCue M, Klein I, et al. Graves’ disease: an analysis of thyroid hormone levels and hyperthyroid signs and symptoms. Am J Med. 1989;87:558–61.

    Article  PubMed  CAS  Google Scholar 

  38. Bahn RS, Burch HB, Cooper DS, et al. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid. 2011;21(6):593–646.

    Article  Google Scholar 

  39. Pearce EN, Farwell AP, Braverman LE. Thyroiditis. N Engl J Med. 2003;348:2646–55.

    Article  PubMed  Google Scholar 

  40. Chen F, Day SL, Metcalfe RA, et al. Characteristics of autoimmune thyroid disease occurring as a late complication of immune reconstitution in patients with advanced human immunodeficiency virus (HIV) disease. Medicine. 2005;84(2):98–106.

    Article  PubMed  CAS  Google Scholar 

  41. Douek DC, McFarland RD, Keiser PH, et al. Changes in thymic function with age and during the treatment of HIV infection. Nature. 1998;396:690–5.

    Article  PubMed  CAS  Google Scholar 

  42. Pakker NG, Notermans DW, de Boer RJ, et al. Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation. Nat Med. 1998;4(2):208.

    Article  PubMed  CAS  Google Scholar 

  43. Autran B, Carcelain G, Li TS, et al. Positive effects of combined antiretroviral therapy on CD + T cell homeostasis and function in advanced HIV disease. Science. 1997;277(5322):112–6.

    Article  PubMed  CAS  Google Scholar 

  44. Imami N, Antonopoulos C, Hardy GA, et al. Assessment of type 1 and type 2 cytokines in HIC type 1 infected individuals: impact of highly active antiretroviral therapy. AIDS Res Hum Retrovir. 1999;15:1499–508.

    Article  PubMed  CAS  Google Scholar 

  45. Mullur M, Wandel S, Colebunders R, et al. Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis. Lancet Infect Dis. 2010;10(4):251–61.

    Article  Google Scholar 

  46. Grant PM, Komarow L, Andersen J, et al. Risk factor analyses for immune reconstitution inflammatory syndrome in a randomized study of early vs. deferred ART during an opportunistic infection. PLoS One. 2010. 5(7). doi:10.1371/journal.pone.0011416

  47. Jubault V, Penfornis A, Schillo F, et al. Sequential occurance of thyroid autoantibodies and Graves disease after immune restoration in severely immunocompromised human immunodeficiency virus-1 infected patients. J Clin Endocrinol Metab. 2000;85:4254–7.

    Article  PubMed  CAS  Google Scholar 

  48. Vos F, Pieters G, Keuter M, van der Ven A. Graves’ disease during immune reconstitution in HIV infected patients treated with HAART. Scand J Infect Dis. 2006;38(2):124–6.

    Article  PubMed  CAS  Google Scholar 

  49. Sawin CT, Geller A, Wolf PA, et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med. 1994;331:1249–52.

    Article  PubMed  CAS  Google Scholar 

  50. Cappola AR, Fried LP, Arnold AM, et al. Thyroid status, cardiovascular risk, and mortality in older adults. JAMA. 2006;295:1033–41.

    Article  PubMed  CAS  Google Scholar 

  51. Cooper DS. Antithyroid drugs. N Engl J Med. 2005;352:905–917.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Endocrinology, Diabetes & Metabolism, Cedars-Sinai Medical Center, Los Angeles, CA, USA

    Alan A. Parsa

  2. Pediatric Endocrinology, Miller Children’s Hospital, Long Beach, CA, USA

    Amrit Bhangoo

Authors
  1. Alan A. Parsa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Amrit Bhangoo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Amrit Bhangoo.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Parsa, A.A., Bhangoo, A. HIV and thyroid dysfunction. Rev Endocr Metab Disord 14, 127–131 (2013). https://doi.org/10.1007/s11154-013-9248-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11154-013-9248-6

Keywords

Search

Navigation